RLAY vs TXN · rev $3.4M vs P/E 52, rev $10.29B
Relay Therapeutics Inc (RLAY) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
RLAY currently screens at market cap $3.39B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the RLAY and TXN stock pages for the full models.
Not investment advice.